Showing 9,881 - 9,900 results of 30,966 for search '(( 50 ((nn decrease) OR (a decrease)) ) OR ( 100 ((ng decrease) OR (mean decrease)) ))', query time: 0.76s Refine Results
  1. 9881

    <i>Hnrnph1</i> Is A Quantitative Trait Gene for Methamphetamine Sensitivity by Neema Yazdani (835533)

    Published 2015
    “…We used interval-specific congenic mouse lines carrying various segments of chromosome 11 from the DBA/2J strain on an isogenic C57BL/6J background to positionally clone a 206 kb QTL (50,185,512–50,391,845 bp) that was causally associated with a reduction in the locomotor stimulant response to methamphetamine (2 mg/kg, i.p.; DBA/2J < C57BL/6J)—a non-contingent, drug-induced behavior that is associated with stimulation of the dopaminergic reward circuitry. …”
  2. 9882

    Treatment with a TRPV agonist reduces the ability of mf to establish infection in mosquitoes. by Nicolas J. Wheeler (8947214)

    Published 2020
    “…<p>(A) NAM added to blood at up to 50 mM increases the proportion of blood-fed mosquitoes when allowed to feed to repletion but reduces mosquito blood feeding at concentrations greater than 50 mM. …”
  3. 9883

    Tuning the Performance of Metalloporphyrin-Based Pressure-Sensitive Paints through the Nature of the Central Metal Ion by Elliott J. Nunn (20445750)

    Published 2024
    “…This new insight into luminophore design can be used to optimize PSPs for a desired application.…”
  4. 9884

    Tuning the Performance of Metalloporphyrin-Based Pressure-Sensitive Paints through the Nature of the Central Metal Ion by Elliott J. Nunn (20445750)

    Published 2024
    “…This new insight into luminophore design can be used to optimize PSPs for a desired application.…”
  5. 9885

    Tuning the Performance of Metalloporphyrin-Based Pressure-Sensitive Paints through the Nature of the Central Metal Ion by Elliott J. Nunn (20445750)

    Published 2024
    “…This new insight into luminophore design can be used to optimize PSPs for a desired application.…”
  6. 9886

    Characteristics of treatment modality. by Adekunle Emmanuel Sajo (15285520)

    Published 2025
    “…The annual average age decreased from 56 years to as low as 40 years, a mean difference of 16 years, p 0.012.…”
  7. 9887

    Demographic and clinical characteristics. by Adekunle Emmanuel Sajo (15285520)

    Published 2025
    “…The annual average age decreased from 56 years to as low as 40 years, a mean difference of 16 years, p 0.012.…”
  8. 9888
  9. 9889
  10. 9890
  11. 9891

    Sequence of <i>DpAP2</i> promoter. by Lingru Ruan (18995544)

    Published 2024
    “…<i>parva</i> cells treated with different concentrations of MeJA (10, 20, 50, 100 μM) and GA3 (10, 20, 50, 100 μM). The high concentrations of MeJA (10–100 μM) inhibited the accumulation of carotenoid, and the relative expression of <i>DpAP2</i>, <i>PSY</i>, <i>PDS</i> and <i>GGPS</i> decreased significantly. …”
  12. 9892
  13. 9893
  14. 9894
  15. 9895
  16. 9896
  17. 9897
  18. 9898
  19. 9899
  20. 9900

    Discovery of N‑Substituted Acetamide Derivatives as Promising P2Y<sub>14</sub>R Antagonists Using Molecular Hybridization Based on Crystallographic Overlay by Wenjin Liu (4016060)

    Published 2024
    “…Thus, compound <b>I-17</b>, with potent P2Y<sub>14</sub>R antagonistic activity, <i>in vitro</i> and <i>in vivo</i> efficacy, and favorable bioavailability (<i>F</i> = 75%), could be a promising lead compound for acute gouty arthritis.…”